Search

everythinglearnresearchcommunity

for

Search:↓

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Notch/CSL signaling controls hair follicle differentiation through Wnt5a and FoxN1.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Janus kinase inhibitors may help treat lichen planopilaris.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Topical Ruxolitinib may safely treat severe hair loss.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib treatment for hair loss may worsen acne.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Upadacitinib may effectively treat resistant lichen planopilaris.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.